Legal & General Group PLC Mustang Bio, Inc. Transaction History

Legal & General Group PLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.46 - $7.2 $2,554 - $39,988	-5,554 Closed	0 $0
Q2 2021 Aug 12, 2021	BUY	$2.7 - $3.81 $24 - $34	9 Added 0.16%	5,554 $18,000
Q4 2020 Feb 12, 2021	BUY	$2.66 - $4.18 $5,628 - $8,844	2,116 Added 61.71%	5,545 $21,000
Q3 2020 Nov 13, 2020	SELL	$3.01 - $3.88 $3,605 - $4,648	-1,198 Reduced 25.89%	3,429 $11,000
Q2 2020 Aug 14, 2020	BUY	$2.33 - $4.6 $69 - $138	30 Added 0.65%	4,627 $15,000
Q1 2020 May 14, 2020	SELL	$1.91 - $4.52 $2,647 - $6,264	-1,386 Reduced 23.17%	4,597 $12,000
Q4 2019 Feb 13, 2020	BUY	$2.57 - $4.08 $3,030 - $4,810	1,179 Added 24.54%	5,983 $24,000
Q2 2019 Aug 14, 2019	BUY	$2.66 - $6.28 $6,203 - $14,644	2,332 Added 94.34%	4,804 $18,000
Q2 2018 Aug 10, 2018	BUY	$6.68 - $11.0 $16,512 - $27,192	2,472 New	2,472 $17,000

415K

Ticker MBIO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 105,222,000
Market Cap $23.1M
Description
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating medical breakthroughs in cell and gene therapies into potential cures for hematologic cancers, solid tumors, and rare genetic diseases. Its pipeline focuses on gene therapy programs for rare genetic disorders, chimeric antigen receptor (CAR) engineered T cell (...

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

Stay updated on Legal & General Group PLC with notifications on news.